StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $285 at JMP Securities
April 30, 2020 4:38 AM
JMP Securities analyst Joseph Osha raised the price target on Vertex (NASDAQ:
VRTX
) to $285.00 (from $255.00) while maintaining a Market Outperform rating.
Categories
Analyst PT Change
Next Articles
Vertex Pharma (VRTX) Granted European CHMP Positive Opinion for KALYDECO for Children/Adolescents with CF and R117H Mutation in CFTR Gene
May 1, 2020 5:50 AM